TWiV 1054: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Dr. Griffin discusses high Influenza incidence and disease severity among children and adolescents aged

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• High Influenza incidence and disease severity among children and adolescents aged
• Neurologic effects of SARS-CoV-2 transmitted among dogs (EID)
• Effectiveness of mRNA vaccines against Omicron XBB infection in Singaporean children (JAMA)
• Effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions (ASHE)
• Incidence and impact of acute pericarditis in hospitalized patients with COVID‐19 (JAHA)
• Serotonin reduction in post-acute sequelae of viral infection (Cell)
• Prevalence and risk factors for long COVID and post-COVID-19 in Africa (The Lancet)
• Safety profile and clinical and virological outcomes of nirmatrelvir-ritonavir treatment in patients with kidney disease and COVID-19 (CID)
• Antiviral efficacy of molnupiravir vs ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19
• Contribute to our Floating Doctors fundraiser at PWB
• Letters read on TWiV 1054
• Dr. Griffin's COVID treatment summary (pdf)
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to daniel@microbe.tv